Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. [electronic resource]
- Emerging infectious diseases Nov 2003
- 1455-7 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1080-6040
10.3201/eid0911.030317 doi
Aged Anti-Infective Agents--therapeutic use Ciprofloxacin--therapeutic use DNA Gyrase--drug effects Drug Resistance, Multiple, Bacterial--genetics Fluoroquinolones--therapeutic use Humans Infant Male Microbial Sensitivity Tests Salmonella Infections--drug therapy Salmonella typhimurium--drug effects